학술논문
Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
Document Type
Review Article
Author
Source
In Brain Hemorrhages April 2024 5(2):91-97
Subject
Language
ISSN
2589-238X